Aktie 634826 ELITE PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Elite Pharmaceuticals, Inc.

Aktien

634826

US28659T2006

ELTP

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:57:52 24.05.2024 		% 5 Tage % 1. Jan.
0,1705 USD +0,89 % Intraday Chart für Elite Pharmaceuticals, Inc. +19,23 % +21,79 %
15.02. Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024
14.02. Elite Pharmaceuticals, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 Ended December 31, 2023 and Provides Conference Call Information
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Elite Pharmaceuticals, Inc. To Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant
Elite Pharmaceuticals, Inc. Files ANDA with US FDA to Market Central Nervous System Stimulant
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR to Marketing Partner Prasco, LLC
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 Ended September 30, 2023 and Provides Conference Call Information
Elite Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOM
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)
Elite Pharmaceuticals Files Anda with US FDA to Market Opiate Analgesic Product
Medical Penny Stocks Making Moves (ORHB, PBIO, INND, ELTP)
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
Penny Stocks In The News Making Moves: EPAZ, HYSR, ELTP, ABML
This Week's Top OTC Nano-Caps (ATVK, ELTP, EBET, ENZC)
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Discover the Potential: "Top Penny Stocks to Watch Now": SNNC, TIVC, ENZC, ELTP, CLNV
CapitalGainsReport: Top Stocks Under Two Cents To Radar Today (ATVK, VDRM, RNVA, ELTP)
CapitalGainsReport: Exploring OTC Penny Stocks' Critical Updates (EPAZ, OZSC, ELTP, SHMP)
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 Ended June 30, 2023 and Provides Conference Call Information
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 634826 Aktie
  4. Nachrichten Elite Pharmaceuticals, Inc.
  5. Andere Sprachen